<PAPER>
  <mode2 name="ehp13_arathi" hasDoc="yes" version="1258"/>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
    <front>
      <journal-meta>
        <journal-id journal-id-type="publisher-id">EHP</journal-id>
        <journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id>
        <journal-title>Environmental Health Perspectives</journal-title>
        <abbrev-journal-title abbrev-type="pubmed">Environ. Health Perspect.</abbrev-journal-title>
        <issn pub-type="epub">0091-6765</issn>
        <publisher>
          <publisher-name>National Institute of Environmental Health Sciences</publisher-name>
        </publisher>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="publisher-id">ehp.02110813</article-id>
        <article-id pub-id-type="doi">10.1289/ehp.02110813</article-id>
        <title-group>
          <article-title>
            <s sid="1">Cytotoxicity of Fumonisin B<sub>1</sub>, Diethylnitrosamine, and Catechol on the SNO Esophageal Cancer Cell Line<CoreSc1 atype="GSC" type="Obj" conceptID="Obj1" novelty="None" advantage="None"/></s>
          </article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author" corresp="yes" xlink:type="simple">
            <name name-style="western">
              <surname>Myburg</surname>
              <given-names>Rene B.</given-names>
            </name>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Dutton</surname>
              <given-names>Michael F.</given-names>
            </name>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Chuturgoon</surname>
              <given-names>Anil A.</given-names>
            </name>
          </contrib>
          <aff id="aff1">
            <addr-line>Department of Physiology, School of Medical Sciences, Nelson R. Mandela School of Medicine, Congella, South Africa</addr-line>
          </aff>
        </contrib-group>
        <author-notes>
          <corresp id="cor1">Address correspondence to R.B. Myburg, Department of Physiology, School of Medical Sciences, Nelson R. Mandela School of Medicine, Private Bag 7, Congella, 4013, South Africa. Telephone: +27-31-260-4404. Fax: +27-31-260-4455. E-mail: <email xlink:type="simple">myburgr@nu.ac.za</email></corresp>
        </author-notes>
        <pub-date pub-type="epub">
          <day>28</day>
          <month>06</month>
          <year>2002</year>
        </pub-date>
        <volume>110</volume>
        <issue>8</issue>
        <fpage>813</fpage>
        <lpage>815</lpage>
        <history>
          <date date-type="received">
            <day>18</day>
            <month>07</month>
            <year>2001</year>
          </date>
          <date date-type="accepted">
            <day>17</day>
            <month>12</month>
            <year>2001</year>
          </date>
        </history>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/" xlink:type="simple">
          <p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
        </license>
        <permissions>
          <copyright-year>2002</copyright-year>
          <copyright-holder/>
        </permissions>
        <abstract>
          <p>
            <s sid="2">Mycotoxins that commonly contaminate staple food grains pose a health hazard to animals and humans.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/></s>
            <s sid="3">Fumonisin B<sub>1</sub> (FB<sub>1</sub>), a mycotoxin produced by <italic>Fusarium verticillioides</italic>, causes equine leukoencephalomalacia and porcine pulmonary edema and has been implicated in the etiology of esophageal cancer (EC) in the Transkei, South Africa.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/></s>
            <s sid="4">Various studies have indicated that nitrosamines induce EC, and <italic>F. verticillioides</italic> enhancement of nitrosamine-induced EC in rats has been reported.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/></s>
            <s sid="5">Dietary catechol (CAT), a constituent of cigarette smoke, was previously found to be a cocarcinogen with methyl<italic>-N-</italic>nitrosamine for inducing esophageal tumors in rats.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/></s>
            <s sid="6">In the present study we therefore investigated the cytotoxic effects of FB<sub>1</sub>, diethylnitrosamine (DEN), and CAT on a human esophageal epithelial cell line (SNO) using the methylthiazol tetrazolium assay.<CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Obj" conceptID="Obj2" novelty="None" advantage="None"/></s>
            <s sid="7">For each treatment, toxin concentrations ranged from 2.165 to 34.64 &#181;M.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/></s>
            <s sid="8">The results showed that the cytotoxic response of SNO cells was highest in cells treated with 34.64 &#181;M FB<sub>1</sub>.<CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/></s>
            <s sid="9">SNO cells treated with DEN + FB<sub>1</sub> showed greater cytotoxicity than did cells treated with FB<sub>1</sub> alone, whereas FB<sub>1</sub> appeared to inhibit the cytotoxic effect exerted by CAT alone.<CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/></s>
            <s sid="10">The results of this study provide further evidence for the involvement of FB<sub>1</sub> in the etiology of esophageal carcinoma.<CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/></s>
          </p>
        </abstract>
        <kwd-group kwd-group-type="author" xml:lang="EN">
          <kwd>catechol</kwd>
          <kwd>cell culture</kwd>
          <kwd>diethylnitrosamine</kwd>
          <kwd>fumonisin B<sub>1</sub></kwd>
          <kwd>methylthiazol tetrazolium assay</kwd>
        </kwd-group>
      </article-meta>
    </front>
    <body>
      <p>
        <s sid="11">Approximately 60-90% of human cancers are attributable to environmental factors, particularly chemical carcinogens (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/></s>
        <s sid="12">Two important groups of carcinogens that have emerged are the mycotoxins and <italic>N-</italic>nitrosamines.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="13">Fumonisin B<sub>1</sub> (FB<sub>1</sub>) is a mycotoxin produced by the fungus <italic>Fusarium verticillioides</italic>, a ubiquitous soil-borne fungus that frequently contaminates maize and maize products.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj3" novelty="None" advantage="None"/></s>
        <s sid="14">FB<sub>1</sub> is the most abundant and toxic of the known fumonisins and has been associated with many animal diseases, including equine leukoencephalomalacia (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>), porcine pulmonary edema (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>), and liver and kidney tumors in rats (<xref ref-type="bibr" rid="r4"><italic>4</italic></xref>).<CoreSc1 atype="GSC" type="Obj" conceptID="Obj4" novelty="None" advantage="None"/></s>
        <s sid="15">The geographic areas where FB<sub>1</sub> occurs in high concentrations have been associated with high rates of esophageal cancer (EC) in humans (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac6" novelty="None" advantage="None"/></s>
        <s sid="16">Although FB<sub>1</sub> has been classified by the International Agency for Research on Cancer as a type 2B carcinogen (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>) and appears to be an initiator and promotor of carcinogenesis in rats (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>), we have as yet no convincing evidence that FB<sub>1</sub> is a human carcinogen.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot2" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Bac" conceptID="Bac7" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="17">Minute quantities of nitrosamines are present in cigarette smoke, alcoholic beverages, and certain foods, but their cumulative effect over several years could play a role in cancer.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac8" novelty="None" advantage="None"/></s>
        <s sid="18"><italic>N-</italic>nitrosamines are precarcinogens, giving rise to ultimate carcinogens only after enzymatic activation under acidic conditions in the stomach (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac9" novelty="None" advantage="None"/></s>
        <s sid="19">A possible correlation exists between EC and gastrectomy, that is, alkaline reflux into the esophagus.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac10" novelty="None" advantage="None"/></s>
        <s sid="20">This could account for the mechanism by which ultimate carcinogens of nitrosamines reach the esophagus.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac11" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="21"><italic>N-</italic>nitrosamines are organ specific, and in this regard, asymmetrical nitrosamines (e.g., <italic>N-</italic>nitrosomethylalanine and <italic>N-</italic>nitrosopiperidine) have a tendency to induce tumors of the esophagus (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac12" novelty="None" advantage="None"/></s>
        <s sid="22">Mingxin et al. (<xref ref-type="bibr" rid="r9"><italic>9</italic></xref>) found that methylbenzylnitrosamine, nitrososarcosine ethyl ester, and other secondary amines induced carcinoma of the esophagus in rats.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac13" novelty="None" advantage="None"/></s>
        <s sid="23">Harris et al. (<xref ref-type="bibr" rid="r10"><italic>10</italic></xref>) reported that cultured human esophageal cells activated dimethylnitrosamine into DNA-binding metabolites.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac14" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="24"><italic>F. verticillioides</italic> enhancement of nitrosamine-induced EC in rats has been reported by van Rensburg (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac15" novelty="None" advantage="None"/></s>
        <s sid="25">Also, nitrosamines and their precursors have been found in foods from a high-EC area of China (<xref ref-type="bibr" rid="r12"><italic>12</italic></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac16" novelty="None" advantage="None"/></s>
        <s sid="26">These findings suggest that nitrosamines may play a role in the etiology of human esophageal carcinogenesis, possibly by acting synergistically with mycotoxins or other metabolites of <italic>F. verticillioides</italic> (<xref ref-type="bibr" rid="r13"><italic>13</italic></xref>).<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp1" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="27">Excessive exposure to tobacco and alcohol has repeatedly been implicated as a principal factor in carcinoma of the esophagus (<xref ref-type="bibr" rid="r14"><italic>14</italic></xref><italic>,</italic><xref ref-type="bibr" rid="r15"><italic>15</italic></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac17" novelty="None" advantage="None"/></s>
        <s sid="28">Tobacco and tobacco smoke contain many distinct classes of chemical carcinogens and cocarcinogens, including the <italic>N-</italic>nitrosamines, which are important environmental carcinogens.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac18" novelty="None" advantage="None"/></s>
        <s sid="29">Dietary catechol (CAT), a constituent of cigarette smoke, was previously found to be a cocarcinogen with methyl<italic>-N-</italic>nitrosamine (MNAN) for inducing esophageal tumors in rats.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac19" novelty="None" advantage="None"/></s>
        <s sid="30">CAT in drinking water was not significantly cocarcinogenic with MNAN, but ethanol and CAT given in the drinking water was cocarcinogenic with MNAN and tumorigenic when given without MNAN (<xref ref-type="bibr" rid="r16"><italic>16</italic></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac20" novelty="None" advantage="None"/></s>
        <s sid="31">The increased carcinogenicity by MNAN occurs because ethanol and CAT affect MNAN metabolism.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac21" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="32">The human esophageal carcinoma cell line SNO was derived from a well-differentiated squamous cell carcinoma (6.5 cm long and metastatic to the lymph nodes) that was explanted from patient S.N., a 62-year-old Zulu male, in July 1972 (<xref ref-type="bibr" rid="r17"><italic>17</italic></xref>).<CoreSc1 atype="GSC" type="Obj" conceptID="Obj5" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="33">There is sufficient evidence of the carcinogenicity of FB<sub>1</sub> in test animals, but not enough data to draw definite conclusions for humans (<xref ref-type="bibr" rid="r18"><italic>18</italic></xref>).<CoreSc1 atype="GSC" type="Mot" conceptID="Mot3" novelty="None" advantage="None"/></s>
        <s sid="34">We undertook this study to investigate whether FB<sub>1</sub> is an etiologic agent in human esophageal carcinoma, as well as to review the cytotoxic effect of other etiologic factors in this disease.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa1" novelty="None" advantage="None"/></s>
        <s sid="35">In this study we evaluated the cytotoxicity of FB<sub>1</sub>, diethylnitrosamine (DEN), and CAT on the human SNO EC cell line.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj6" novelty="None" advantage="None"/></s>
      </p>
      <sec sec-type="materials|methods">
        <title>Materials and Methods</title>
        <p>
          <s sid="36"><bold><italic>Materials.</italic></bold> We purchased all cell culture media and plasticware from Sterilin (Durban, South Africa).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/></s>
          <s sid="37">We obtained methylthiazol tetrazolium (MTT) salt, DEN, and CAT from Sigma Chemical Company (St. Louis, MO, USA) and FB<sub>1</sub> from the Programme on Mycotoxins and Experimental Carcinogenesis (Cape Town, South Africa).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp3" novelty="None" advantage="None"/></s>
          <s sid="38">We purchased all solvents from Merck (Johannesburg, South Africa).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp4" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="39"><bold><italic>Preparation of toxin stock solutions.</italic></bold> We prepared stock solutions of FB<sub>1</sub>, DEN, and CAT by dissolving 0.5 mg of each toxin in 30 &#181;L ethanol, 170 &#181;L dimethyl sulfoxide (DMSO), and 4.8 mL complete culture medium (CCM; minimum essential medium supplemented with 5% fetal calf serum, 1% Penstrep fungizone, and 1% l-glutamine), thus yielding a toxin concentration of 100 &#181;M.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp5" novelty="None" advantage="None"/></s>
          <s sid="40">The control stock solution contained ethanol, DMSO, and CCM.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/></s>
          <s sid="41">For the cytotoxicity assay, we used serial dilutions (2.165-34.64 &#181;M) prepared from the stock solution.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="42"><bold><italic>Preparation of the MTT salt.</italic></bold> We dissolved MTT salt (5 mg) in 1 mL Hank's balanced salt solution (HBSS) to give a concentration of 5 mg/mL.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/></s>
          <s sid="43">We then filtered the suspension through a 0.45-&#181;m filter and stored it in the dark at room temperature until use.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="44"><bold><italic>The MTT assay.</italic></bold> We determined the cytotoxic effect of the toxins on SNO cells using the MTT assay.<CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="None" advantage="None"/></s>
          <s sid="45">We washed two confluent monolayers in 75-cm<sup>3</sup> culture flasks in CCM with HBSS, which we then trypsinized to detach cells from the flask.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/></s>
          <s sid="46">We removed the trypsin and replaced it with 15 mL CCM and gently shook the flasks to dislodge the cells.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/></s>
          <s sid="47">We assessed cell viability using trypan blue, determined cell numbers using a hemocytometer (<xref ref-type="bibr" rid="r19"><italic>19</italic></xref>), and resuspended cells to give a cell count of 4.5 &#215; 10<sup>6</sup> cells.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/></s>
          <s sid="48">We aliquoted the cell suspension (100 &#181;L) into each well of two 96-well tissue culture plates and incubated them at 37&#176;C.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="49">After 24 hr, we replaced the CCM with 100 &#181;L toxin at concentrations ranging from 2.165 to 34.64 &#181;M, using five replicates for each serial dilution.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/></s>
          <s sid="50">After a 48-hr incubation at 37&#176;C, we removed the toxin and replaced it with 10 &#181;L MTT (5 mg/mL) and 100 &#181;L CCM, and then incubated the mixture for a further 4 hr.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/></s>
          <s sid="51">We subsequently removed the supernatant and aliquoted 100 &#181;L DMSO into each well to solubilize any resulting formazan crystals.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/></s>
          <s sid="52">After 1 hr, we determined the optical density of the resulting solution spectrophotometrically using a Bio-Rad (Johannesburg, South Africa) multiwell plate reader at 595 nm and a reference wavelength of 630 nm.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp17" novelty="None" advantage="None"/></s>
          <s sid="53">We calculated cell viability from the absorbance values obtained.<CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="54">We then statistically analyzed the results using one-way analysis of variance (ANOVA) for multiple comparisons and Student's <italic>t</italic>-test and the Mann<italic>-</italic>Whitney rank sum test for two-group comparisons.<CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="None" advantage="None"/></s>
          <s sid="55">We constructed graphs to illustrate cell viability after calculation of the standard deviation.<CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="None" advantage="None"/></s>
          <s sid="56">We considered data comparisons significant if <italic>p</italic> &lt; 0.05.<CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="None" advantage="None"/></s>
        </p>
      </sec>
      <sec sec-type="results|discussion">
        <title>Results and Discussion</title>
        <p>
          <s sid="57">In this study we evaluated the cytotoxic effect of FB<sub>1</sub> and other etiologic agents (DEN and CAT) on SNO cells using the MTT assay.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj7" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="58">We observed minimal cytotoxicity in SNO cells exposed to FB<sub>1</sub> over 48 hr compared with control cells (<xref ref-type="fig" rid="f1">Figures 1</xref> and <xref ref-type="fig" rid="f2">2</xref>), with FB<sub>1</sub>-treated cells showing a 23% cell mortality after 48-hr incubation with 34.64 &#181;M FB<sub>1</sub> (<italic>p</italic> &lt; 0.022).<CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/></s>
          <s sid="59">The low cytotoxic response by SNO cells at the concentrations tested is in agreement with other studies.<CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/></s>
          <s sid="60">Cawood et al. (<xref ref-type="bibr" rid="r20"><italic>20</italic></xref>) noted a low cytotoxic response in primary hepatocytes.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac22" novelty="None" advantage="None"/></s>
          <s sid="61">However, FB<sub>1</sub> has been shown to be cytotoxic to certain mammalian cell lines (<xref ref-type="bibr" rid="r21"><italic>21</italic></xref><italic>,</italic><xref ref-type="bibr" rid="r22"><italic>22</italic></xref>), suggesting that some tissue may accumulate FB<sub>1</sub> over time or may be more susceptible to the cancer-promoting ability of FB<sub>1</sub>.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac23" novelty="None" advantage="None"/></s>
          <s sid="62">The effects of FB<sub>1</sub> are chronic, as suggested by the late age of onset of EC (between 40 and 60 years).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac24" novelty="None" advantage="None"/></s>
          <s sid="63">FB<sub>1</sub> is also poorly absorbed (experiments show that 90% of FB<sub>1</sub> is directly excreted), which explains why FB<sub>1</sub> is a slow-acting carcinogen (<xref ref-type="bibr" rid="r23"><italic>23</italic></xref>).<CoreSc1 atype="GSC" type="Obj" conceptID="Obj8" novelty="None" advantage="None"/></s>
        </p>
        <fig fig-type="figure" id="f1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Cell viability of control, FB<sub>1</sub>-treated, DEN<italic>-</italic>treated, and DEN+FB<sub>1</sub>-treated SNO cells after 48-hr exposure to the toxins.</p>
          </caption>
          <p>Significant difference between *control and FB<sub>1</sub>; <sup>#</sup>FB<sub>1</sub> and DEN + FB<sub>1</sub> (<italic>p</italic> &lt; 0.05, Student's <italic>t</italic>-test and Mann-Whitney rank sum test).</p>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.02110813.g001" xlink:type="simple"/>
        </fig>
        <fig fig-type="figure" id="f2" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Cell viability of control, FB<sub>1</sub>-treated, CAT-treated, and CAT+FB<sub>1</sub>-treated SNO cells after 48-hr exposure to the toxins.</p>
          </caption>
          <p>Significant difference between *control and FB<sub>1</sub>; <sup>#</sup>FB<sub>1</sub> and CAT + FB<sub>1</sub> (<italic>p</italic> &lt; 0.05, Student's <italic>t</italic>-test and Mann-Whitney rank sum test).</p>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.02110813.g002" xlink:type="simple"/>
        </fig>
        <p>
          <s sid="64">Apart from a chronic effect, the low toxic response over 48 hr by cells treated with FB<sub>1</sub> may suggest that FB<sub>1</sub> is more effective as a cancer promoter than an initiator of EC in humans.<CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/></s>
          <s sid="65">This disagrees with studies that show a toxic effect by FB<sub>1</sub> in rat liver and kidney.<CoreSc1 atype="GSC" type="Res" conceptID="Res5" novelty="None" advantage="None"/></s>
          <s sid="66">The presence of an amino group and the location of the hydroxyl on C<sub>14</sub>/C<sub>15</sub> may also play an important role in both the toxic and cancer-initiating activities of FB<sub>1</sub>.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj9" novelty="None" advantage="None"/></s>
          <s sid="67">The presence of the amino group facilitates the conjugation of FB<sub>1</sub> via gluteraldehyde to protein carriers (<xref ref-type="bibr" rid="r24"><italic>24</italic></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac25" novelty="None" advantage="None"/></s>
          <s sid="68">This would provide a plausible mechanism by which FB<sub>1</sub> exerts its mitogenic effect.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac26" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="69">Cytotoxicity depends on the ability of a molecule to bind cellular receptors and/or penetrate the cell membrane (dependent on size, structural conformation, and polarity of the compound).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac27" novelty="None" advantage="None"/></s>
          <s sid="70">Polarity appears to be an important determinant in the cytotoxic behavior of FB<sub>1</sub>.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac28" novelty="None" advantage="None"/></s>
          <s sid="71">In general, less polar molecules have higher cytotoxicity (<xref ref-type="bibr" rid="r25"><italic>25</italic></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac29" novelty="None" advantage="None"/></s>
          <s sid="72">FB<sub>1</sub> is a strongly polar compound (<xref ref-type="bibr" rid="r26"><italic>26</italic></xref>).<CoreSc1 atype="GSC" type="Obj" conceptID="Obj10" novelty="None" advantage="None"/></s>
          <s sid="73">This explains the low cytotoxic response observed on treatment with FB<sub>1</sub>.<CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="74">Another possibility is that FB<sub>1</sub> acts in synergy with a cocarcinogen that forms part of the etiology of EC.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp2" novelty="None" advantage="None"/></s>
          <s sid="75">It therefore appears that SNO cells are more susceptible to combined treatment with DEN and FB<sub>1</sub>.<CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/></s>
          <s sid="76">One-way ANOVA revealed a significant difference between treatment with FB<sub>1</sub> alone compared with treatment with DEN + FB<sub>1</sub> at 34.64 &#181;M (<italic>p</italic> &lt; 0.043), 17.32 &#181;M (<italic>p</italic> &lt; 0.008), 8.66 &#181;M (<italic>p</italic> &lt; 0.005), and 4.33 &#181;M (<italic>p</italic> &lt; 0.03).<CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/></s>
          <s sid="77">A cell mortality of 37% occurred upon treatment with DEN + FB<sub>1</sub> (34.64 &#181;M).<CoreSc1 atype="GSC" type="Res" conceptID="Res7" novelty="None" advantage="None"/></s>
          <s sid="78">At the same concentration, we observed only 9% cell mortality upon treatment with DEN alone.<CoreSc1 atype="GSC" type="Res" conceptID="Res8" novelty="None" advantage="None"/></s>
          <s sid="79"><xref ref-type="fig" rid="f1">Figure 1</xref> shows the differences observed in cell viability after treating SNO cells with FB<sub>1</sub>, DEN, and DEN + FB<sub>1</sub>.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="80">DEN is part of a widely acting group of potent carcinogens.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj11" novelty="None" advantage="None"/></s>
          <s sid="81">Nitrosamines are metabolized by mixed-function oxidase enzymes to a chemically active alkylating agent in the rat and possibly in the human esophagus (<xref ref-type="bibr" rid="r27"><italic>27</italic></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac30" novelty="None" advantage="None"/></s>
          <s sid="82">This reaction produces alkylating intermediates that can form O<sup>6</sup>-alkylguanines from DNA guanine.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac31" novelty="None" advantage="None"/></s>
          <s sid="83">DNA guanine then pairs with thymine rather than cytosine.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac32" novelty="None" advantage="None"/></s>
          <s sid="84">It is thought that this mispairing produces a mutation that initiates carcinogenesis (<xref ref-type="bibr" rid="r28"><italic>28</italic></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac33" novelty="None" advantage="None"/></s>
          <s sid="85">In support of this view, we detected elevated levels of O<sup>6</sup>-methylguanine in esophageal DNA extracted from EC patients in China (<xref ref-type="bibr" rid="r29"><italic>29</italic></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac34" novelty="None" advantage="None"/></s>
          <s sid="86">When nitrosamines alkylate rat esophageal DNA and thereby initiate cancer, they are presumably activated by microsomes in the rat esophagus because the active metabolites do not travel in the blood from other organs to the esophagus (<xref ref-type="bibr" rid="r24"><italic>24</italic></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac35" novelty="None" advantage="None"/></s>
          <s sid="87">The same may apply to nitrosamine induction of EC in humans.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp3" novelty="None" advantage="None"/></s>
          <s sid="88">The results suggest that DEN acts in concert with FB<sub>1</sub> and may act as a cancer initiator to promote the activity of FB<sub>1</sub>.<CoreSc1 atype="GSC" type="Con" conceptID="Con5" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="89">The cytotoxicities of FB<sub>1</sub>, CAT, and CAT + FB<sub>1</sub> are shown in <xref ref-type="fig" rid="f2">Figure 2</xref>.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/></s>
          <s sid="90">CAT is cytotoxic to SNO cells, producing 44% cell mortality at 34.64 &#181;M (<italic>p</italic> &lt; 0.03).<CoreSc1 atype="GSC" type="Res" conceptID="Res9" novelty="None" advantage="None"/></s>
          <s sid="91">This agrees with epidemiologic studies that have clearly demonstrated a strong positive association of chronic tobacco smoking with EC (<xref ref-type="bibr" rid="r14"><italic>14</italic></xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac36" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/></s>
          <s sid="92">We also observed a significant difference between FB<sub>1</sub> treatment and FB<sub>1</sub> + CAT at 4.33 &#181;M (<italic>p</italic> &lt; 0.01) and 2.165 &#181;M (<italic>p</italic> &lt; 0.038).<CoreSc1 atype="GSC" type="Res" conceptID="Res10" novelty="None" advantage="None"/></s>
          <s sid="93">However, we found no significant differences in cytotoxic activity between treatment with FB<sub>1</sub> alone and FB<sub>1</sub> + CAT (23% and 28% cell death, respectively) when we assessed the entire range of concentrations against each other.<CoreSc1 atype="GSC" type="Res" conceptID="Res11" novelty="None" advantage="None"/></s>
          <s sid="94">When CAT and FB<sub>1</sub> co-occur, there seems to be a stimulation of cell growth or a reduction in mitochondrial dehydrogenase activity.<CoreSc1 atype="GSC" type="Res" conceptID="Res12" novelty="None" advantage="None"/></s>
          <s sid="95">The results of this study suggest that FB<sub>1</sub> inhibits the effect of CAT on the cells, possibly by reducing binding sites for the toxin.<CoreSc1 atype="GSC" type="Con" conceptID="Con7" novelty="None" advantage="None"/></s>
        </p>
      </sec>
      <sec sec-type="conclusions">
        <title>Conclusions</title>
        <p>
          <s sid="96">The results show that FB<sub>1</sub> alone is not overtly cytotoxic in humans, but that it may act as a promotor or initiator of carcinogenesis in synergy with certain cocarcinogens.<CoreSc1 atype="GSC" type="Con" conceptID="Con8" novelty="None" advantage="None"/></s>
          <s sid="97">Future studies will involve the treatment and immunolocalization of FB<sub>1</sub> in SNO cells, using light and electron microscopy.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot4" novelty="None" advantage="None"/></s>
          <s sid="98">In addition, we know that FB<sub>1</sub> alters sphingolipid metabolism.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac37" novelty="None" advantage="None"/></s>
          <s sid="99">We will therefore expose SNO cells to sphinganine and FB<sub>1</sub> to determine the cytotoxic effect on this cell line.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot5" novelty="None" advantage="None"/></s>
        </p>
      </sec>
    </body>
    <back>
      <ack>
        <p>We thank the University of Natal Research Fund and the Cancer Association of South Africa for funding this study.</p>
      </ack>
      <ref-list>
        <title>References and Notes</title>
        <ref id="r1">
          <label>1</label>
          <citation citation-type="book" xlink:type="simple">
            <comment>Fong LYY. Environmental carcinogens and dietary deficiencies in esophageal cancer in Asia. In: Cancer of the Esophagus (Pfeiffer CJ, ed). Boca Raton, FL:CRC Press, 1982;41-63.</comment>
          </citation>
        </ref>
        <ref id="r2">
          <label>2</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Marasas</surname>
                <given-names>WFO</given-names>
              </name>
              <name name-style="western">
                <surname>Kellerman</surname>
                <given-names>TS</given-names>
              </name>
              <name name-style="western">
                <surname>Gelderblom</surname>
                <given-names>WCA</given-names>
              </name>
              <name name-style="western">
                <surname>Coetzer</surname>
                <given-names>JAW</given-names>
              </name>
              <name name-style="western">
                <surname>Thiel</surname>
                <given-names>FG</given-names>
              </name>
              <name name-style="western">
                <surname>van der Lugt</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Leukoencephalomalacia in a horse induced by fumonisin B<sub>1</sub> isolated from <italic>Fusarium moniliforme</italic>.</article-title>
            <source>Onderspoort J Vet Res</source>
            <volume>55</volume>
            <fpage>197</fpage>
            <lpage>203</lpage>
            <year>1988</year>
          </citation>
        </ref>
        <ref id="r3">
          <label>3</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Harrison</surname>
                <given-names>LR</given-names>
              </name>
              <name name-style="western">
                <surname>Colvin</surname>
                <given-names>BM</given-names>
              </name>
              <name name-style="western">
                <surname>Greene</surname>
                <given-names>JT</given-names>
              </name>
              <name name-style="western">
                <surname>Newman</surname>
                <given-names>LE</given-names>
              </name>
              <name name-style="western">
                <surname>Cole</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary oedema and hydrothorax in swine produced by fumonisin B<sub>1</sub>, a toxic metabolite of <italic>Fusarium moniliforme.</italic></article-title>
            <source>J Vet Diagn Invest</source>
            <volume>2</volume>
            <fpage>217</fpage>
            <lpage>221</lpage>
            <year>1990</year>
          </citation>
        </ref>
        <ref id="r4">
          <label>4</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Gelderblom</surname>
                <given-names>WCA</given-names>
              </name>
              <name name-style="western">
                <surname>Kriek</surname>
                <given-names>NPJ</given-names>
              </name>
              <name name-style="western">
                <surname>Marasas</surname>
                <given-names>WFO</given-names>
              </name>
              <name name-style="western">
                <surname>Thiel</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Toxicity and carcinogenicity of the <italic>Fusarium moniliforme</italic> metabolite, fumonisin B<sub>1</sub> in rats.</article-title>
            <source>Carcinogenesis</source>
            <volume>12</volume>
            <fpage>1247</fpage>
            <lpage>1251</lpage>
            <year>1991</year>
          </citation>
        </ref>
        <ref id="r5">
          <label>5</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Rheeder</surname>
                <given-names>JP</given-names>
              </name>
              <name name-style="western">
                <surname>Sydenham</surname>
                <given-names>EW</given-names>
              </name>
              <name name-style="western">
                <surname>Marasas</surname>
                <given-names>WFO</given-names>
              </name>
              <name name-style="western">
                <surname>Thiel</surname>
                <given-names>PG</given-names>
              </name>
              <name name-style="western">
                <surname>Shepherd</surname>
                <given-names>GS</given-names>
              </name>
              <name name-style="western">
                <surname>van Schalkwyk</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title><italic>Fusarium moniliforme</italic> and fumonisins in corn in relation to human oesophageal cancer in Transkei.</article-title>
            <source>Phytopathology</source>
            <volume>82</volume>
            <fpage>353</fpage>
            <lpage>357</lpage>
            <year>1992</year>
          </citation>
        </ref>
        <ref id="r6">
          <label>6</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <collab xlink:type="simple">IARC</collab>
            </person-group>
            <article-title>Heterocyclic amines.</article-title>
            <source>IARC Monogr Eval Carcinog Risks Hum</source>
            <volume>56</volume>
            <fpage>107</fpage>
            <lpage>108</lpage>
            <year>1993</year>
          </citation>
        </ref>
        <ref id="r7">
          <label>7</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Gelderblom</surname>
                <given-names>WCA</given-names>
              </name>
              <name name-style="western">
                <surname>Marasas</surname>
                <given-names>WFO</given-names>
              </name>
              <name name-style="western">
                <surname>Vleggaar</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Thiel</surname>
                <given-names>PG</given-names>
              </name>
              <name name-style="western">
                <surname>Cawood</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Fumonisins: isolation, chemical characterisation and biological effects.</article-title>
            <source>Mycopathologia</source>
            <volume>117</volume>
            <fpage>11</fpage>
            <lpage>16</lpage>
            <year>1992</year>
          </citation>
        </ref>
        <ref id="r8">
          <label>8</label>
          <citation citation-type="book" xlink:type="simple">
            <comment>Louis CJ. Tumours: Basic Principles and Clinical Aspects. Edinburgh:Churchill Livingstone, 1978.</comment>
          </citation>
        </ref>
        <ref id="r9">
          <label>9</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Mingxin</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Ping</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Baorong</surname>
                <given-names>L.</given-names>
              </name>
            </person-group>
            <article-title>Recent progress in research on oesophageal cancer in China.</article-title>
            <source>Adv Cancer Res</source>
            <volume>33</volume>
            <fpage>173</fpage>
            <lpage>249</lpage>
            <year>1980</year>
          </citation>
        </ref>
        <ref id="r10">
          <label>10</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Harris</surname>
                <given-names>CC</given-names>
              </name>
              <name name-style="western">
                <surname>Autrup</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Stoner</surname>
                <given-names>GD</given-names>
              </name>
              <name name-style="western">
                <surname>Trump</surname>
                <given-names>BF</given-names>
              </name>
              <name name-style="western">
                <surname>Hillman</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Schafer</surname>
                <given-names>PW</given-names>
              </name>
              <name name-style="western">
                <surname>Jeffrey</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Metabolism of benzo(<italic>a</italic>)pyrene, <italic>N-</italic>nitrosodimethylamine, and <italic>N-</italic>nitrosopyrrolidine and identification of major carcinogen<italic>-</italic>DNA adducts formed in cultured human esophagus.</article-title>
            <source>Cancer Res</source>
            <volume>39</volume>
            <fpage>4401</fpage>
            <lpage>4406</lpage>
            <year>1979</year>
          </citation>
        </ref>
        <ref id="r11">
          <label>11</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>van Rensburg</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Esophageal cancer micronutrient malnutrition, and silica fragments.</article-title>
            <source>Lancet</source>
            <volume>2</volume>
            <fpage>1098</fpage>
            <lpage>1099</lpage>
            <year>1982</year>
          </citation>
        </ref>
        <ref id="r12">
          <label>12</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Yang</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Research on oesophageal cancer in China: a review.</article-title>
            <source>Cancer Res</source>
            <volume>40</volume>
            <fpage>2633</fpage>
            <lpage>2644</lpage>
            <year>1980</year>
          </citation>
        </ref>
        <ref id="r13">
          <label>13</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Voss</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Toxins from <italic>Fusarium moniliforme</italic>, a common fungus in corn.</article-title>
            <source>Vet Hum Toxicol</source>
            <volume>32</volume>
            <fpage>57</fpage>
            <lpage>63</lpage>
            <year>1990</year>
          </citation>
        </ref>
        <ref id="r14">
          <label>14</label>
          <citation citation-type="book" xlink:type="simple">
            <comment>Ming Xin L, Shi Jun Cheng. Etiology of carcinoma of the oesophagus. In: Carcinoma of the Oesophagus and Gastric Cardia (Huang GJ, Kai WY, eds). Berlin:Springer-Verlag, 1984;26-51.</comment>
          </citation>
        </ref>
        <ref id="r15">
          <label>15</label>
          <citation citation-type="book" xlink:type="simple">
            <comment>Rose EF. Esophageal cancer in the Transkei--the pattern and associated risk factors. In: Cancer of the Esophagus (Pfeiffer CJ, ed). Boca Raton, FL:CRC Press, 1982;19-28.</comment>
          </citation>
        </ref>
        <ref id="r16">
          <label>16</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Mirvish</surname>
                <given-names>SS</given-names>
              </name>
              <name name-style="western">
                <surname>Weisenburger</surname>
                <given-names>DD</given-names>
              </name>
              <name name-style="western">
                <surname>Henrichs</surname>
                <given-names>SH</given-names>
              </name>
              <name name-style="western">
                <surname>Nickols</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Hinman</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Effect of catechol and ethanol with and without methylamylnitrosamine on oesophageal carcinogenesis in the rat.</article-title>
            <source>Carcinogenesis</source>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>883</fpage>
            <lpage>887</lpage>
            <year>1994</year>
          </citation>
        </ref>
        <ref id="r17">
          <label>17</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Bey</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Alexander</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Whitcutt</surname>
                <given-names>JM</given-names>
              </name>
              <name name-style="western">
                <surname>Hunt</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Gear</surname>
                <given-names>JHS</given-names>
              </name>
            </person-group>
            <article-title>Carcinoma of the esophagus in Africans: establishment of a continuously growing cell line from a tumor specimen.</article-title>
            <source>In Vitro</source>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>107</fpage>
            <lpage>114</lpage>
            <year>1976</year>
          </citation>
        </ref>
        <ref id="r18">
          <label>18</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Norred</surname>
                <given-names>WP</given-names>
              </name>
            </person-group>
            <article-title>Fumonisins--mycotoxins produced.</article-title>
            <source>Environ Health</source>
            <volume>38</volume>
            <fpage>309</fpage>
            <lpage>328</lpage>
            <year>1993</year>
          </citation>
        </ref>
        <ref id="r19">
          <label>19</label>
          <citation citation-type="book" xlink:type="simple">
            <comment>Freshney IR. Culture of Animal Cells: A Manual of Basic Technique. 1st ed. New York:Alan RS Incorporated, 1983.</comment>
          </citation>
        </ref>
        <ref id="r20">
          <label>20</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Cawood</surname>
                <given-names>ME</given-names>
              </name>
              <name name-style="western">
                <surname>Gelderblom</surname>
                <given-names>WCA</given-names>
              </name>
              <name name-style="western">
                <surname>Alberts</surname>
                <given-names>IF</given-names>
              </name>
              <name name-style="western">
                <surname>Snyman</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Interaction of <sup>14</sup>C-labelled fumonisin B mycotoxins with primary rat hepatocyte cultures.</article-title>
            <source>Food Chem Toxicol</source>
            <volume>32</volume>
            <issue>7</issue>
            <fpage>627</fpage>
            <lpage>632</lpage>
            <year>1994</year>
          </citation>
        </ref>
        <ref id="r21">
          <label>21</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Abbas</surname>
                <given-names>HK</given-names>
              </name>
              <name name-style="western">
                <surname>Gelderblom</surname>
                <given-names>WCA</given-names>
              </name>
              <name name-style="western">
                <surname>Cawood</surname>
                <given-names>ME</given-names>
              </name>
              <name name-style="western">
                <surname>Shier</surname>
                <given-names>WT</given-names>
              </name>
            </person-group>
            <article-title>Biological activities of fumonisins, mycotoxins from <italic>Fusarium moniliforme</italic>, in jimsonweed and mammalian cell cultures.</article-title>
            <source>Toxicon</source>
            <volume>31</volume>
            <fpage>345</fpage>
            <lpage>353</lpage>
            <year>1993</year>
          </citation>
        </ref>
        <ref id="r22">
          <label>22</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Shier</surname>
                <given-names>WT</given-names>
              </name>
              <name name-style="western">
                <surname>Abbas</surname>
                <given-names>HK</given-names>
              </name>
              <name name-style="western">
                <surname>Mirocha</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Toxicity of the mycotoxins fumonisins B<sub>1</sub> and B<sub>2</sub> and <italic>Alternaria alternata</italic> f. sp. <italic>lycopersici</italic> toxin (AAL) in cultured mammalian cells.</article-title>
            <source>Mycopathologia</source>
            <volume>116</volume>
            <fpage>97</fpage>
            <lpage>104</lpage>
            <year>1991</year>
          </citation>
        </ref>
        <ref id="r23">
          <label>23</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Dutton</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Fumonisins, mycotoxins of increasing importance: their nature and their effects.</article-title>
            <source>Pharmacol Ther</source>
            <volume>70</volume>
            <fpage>137</fpage>
            <lpage>161</lpage>
            <year>1996</year>
          </citation>
        </ref>
        <ref id="r24">
          <label>24</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Azcona-Oliviera</surname>
                <given-names>JI</given-names>
              </name>
              <name name-style="western">
                <surname>Abouzied</surname>
                <given-names>MM</given-names>
              </name>
              <name name-style="western">
                <surname>Plattner</surname>
                <given-names>RD</given-names>
              </name>
              <name name-style="western">
                <surname>Pestka</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Production of monoclonal antibodies to the mycotoxins fumonisins B<sub>1</sub>, B<sub>2</sub> and B<sub>3</sub>.</article-title>
            <source>J Agric Food Chem</source>
            <volume>40</volume>
            <fpage>531</fpage>
            <lpage>534</lpage>
            <year>1992</year>
          </citation>
        </ref>
        <ref id="r25">
          <label>25</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Gelderblom</surname>
                <given-names>WCA</given-names>
              </name>
              <name name-style="western">
                <surname>Cawood</surname>
                <given-names>ME</given-names>
              </name>
              <name name-style="western">
                <surname>Snyman</surname>
                <given-names>SD</given-names>
              </name>
              <name name-style="western">
                <surname>Vleggaar</surname>
                <given-names>R.</given-names>
              </name>
              <name name-style="western">
                <surname>Marasas</surname>
                <given-names>WFO.</given-names>
              </name>
            </person-group>
            <article-title>Structure-activity relationships of fumonisins in short-term carcinogenesis and cytotoxicity assays.</article-title>
            <source>Food Chem Toxicol</source>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>407</fpage>
            <lpage>414</lpage>
            <year>1993</year>
          </citation>
        </ref>
        <ref id="r26">
          <label>26</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Diaz</surname>
                <given-names>GJ</given-names>
              </name>
              <name name-style="western">
                <surname>Boermans</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Fumonisin toxicoses in domestic animals: a review.</article-title>
            <source>Vet Hum Toxicol</source>
            <volume>36</volume>
            <issue>6</issue>
            <fpage>548</fpage>
            <lpage>555</lpage>
            <year>1994</year>
          </citation>
        </ref>
        <ref id="r27">
          <label>27</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Mirvish</surname>
                <given-names>SS</given-names>
              </name>
              <name name-style="western">
                <surname>Huang</surname>
                <given-names>Q</given-names>
              </name>
              <name name-style="western">
                <surname>Chen</surname>
                <given-names>SC</given-names>
              </name>
              <name name-style="western">
                <surname>Birt</surname>
                <given-names>DF</given-names>
              </name>
              <name name-style="western">
                <surname>Clark</surname>
                <given-names>GW</given-names>
              </name>
              <name name-style="western">
                <surname>Hinder</surname>
                <given-names>RA</given-names>
              </name>
              <name name-style="western">
                <surname>Smyrk</surname>
                <given-names>TC</given-names>
              </name>
              <name name-style="western">
                <surname>de Meester</surname>
                <given-names>TR</given-names>
              </name>
            </person-group>
            <article-title>Metabolism of carcinogenic nitrosamines in the rat and human oesophagus and induction of oesophageal adenocarcinoma in rats.</article-title>
            <source>Endoscopy</source>
            <volume>25</volume>
            <issue>9</issue>
            <fpage>627</fpage>
            <lpage>631</lpage>
            <year>1993</year>
          </citation>
        </ref>
        <ref id="r28">
          <label>28</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Xia</surname>
                <given-names>QJ</given-names>
              </name>
              <name name-style="western">
                <surname>Zhan</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Fungal invasion in oesophageal tissue and its possible relation to oesophageal carcinoma.</article-title>
            <source>Chin Med J</source>
            <volume>58</volume>
            <issue>7</issue>
            <fpage>392</fpage>
            <lpage>396</lpage>
            <year>1978</year>
          </citation>
        </ref>
        <ref id="r29">
          <label>29</label>
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Umbenhauer</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Wild</surname>
                <given-names>CP</given-names>
              </name>
              <name name-style="western">
                <surname>Momtesano</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Saffhill</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Boyle</surname>
                <given-names>JM</given-names>
              </name>
              <name name-style="western">
                <surname>Huh</surname>
                <given-names>N</given-names>
              </name>
              <name name-style="western">
                <surname>Kirstein</surname>
                <given-names>U</given-names>
              </name>
              <name name-style="western">
                <surname>Thomale</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Rajewsky</surname>
                <given-names>MF</given-names>
              </name>
              <name name-style="western">
                <surname>Lu</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>O<sup>6</sup>-methyldeoxyguanine in oesophageal DNA among individuals at high risk of oesophageal carcinoma.</article-title>
            <source>Int J Cancer</source>
            <volume>36</volume>
            <issue>6</issue>
            <fpage>661</fpage>
            <lpage>665</lpage>
            <year>1985</year>
          </citation>
        </ref>
      </ref-list>
    </back>
  </article>
</PAPER>